한글목차

전임상 CRO 시장은 2024-2029년간 27억 3,480만 달러 확대되고, 예측 기간 동안 8.1%의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다. 세계의 전임상 CRO 시장에 대해 조사 분석했으며, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더에 대한 벤더 분석 등의 정보를 전해드립니다.

현재의 시장 시나리오, 최신 동향 및 성장요인, 전체 시장 환경에 대한 최신 분석을 제공합니다. 이 시장은 만성 질환의 유병률 증가, 의료 인프라의 기술 및 발전, 전임상 CRO와 관련된 비 핵심 기능의 아웃소싱의 성장에 의해 주도되고 있습니다.

이 보고서는 업계 주요 참가자들의 의견을 포함하여 1차 및 2차 정보를 객관적으로 결합하여 수행되었습니다. 보고서에는 주요 기업 분석, 종합적인 시장 규모 데이터, 지역별 분석에 따른 부문, 공급업체 현황이 포함되어 있습니다. 보고서에는 과거 데이터와 예측 데이터가 있습니다.

이 보고서는 향후 몇 년동안 전임상 CRO 시장의 성장을 가속하는 주요 요인 중 하나로 임상시험 수 증가를 꼽았습니다. 또한, 의약품 개발을 위한 R&D 예산 증가, 신약 및 치료제에 대한 수요 증가는 시장의 큰 수요로 이어질 것입니다.

목차

제1장 주요 요약

• 시장 개요

제2장 Technavio 분석

• 가격, 수명주기, 고객 구입 바스켓, 채택 비율, 구입 기준 분석
• 인풋의 중요성과 차별화 요인
• 혼란 요인
• 성장 촉진요인과 과제의 영향

제3장 시장 구도

• 시장 생태계
• 시장 특징
• 밸류체인 분석

제4장 시장 규모

• 시장의 정의
• 시장 부문 분석
• 시장 규모(2024년)
• 시장 전망(2024-2029년)

제5장 시장 규모 실적

• 세계의 전임상 CRO 시장(2019-2023년)
• 최종사용자별 부문 분석(2019-2023년)
• 서비스별 부문 분석(2019-2023년)
• 지역별 부문 분석(2019-2023년)
• 국가별 부문 분석(2019-2023년)

제6장 정성 분석

• AI의 영향 : 전임상 CRO 시장

제7장 Five Forces 분석

• Five Forces 요약
• 바이어의 교섭력
• 공급 기업의 교섭력
• 신규 진출업체의 위협
• 대체품의 위협
• 경쟁 위협
• 시장 현황

제8장 시장 세분화 : 최종사용자별

• 시장 부문
• 비교 : 최종사용자별
• P&B 기업 : 시장 규모와 예측(2024-2029년)
• 의료기기 기업 : 시장 규모와 예측(2024-2029년)
• 학술기관 : 시장 규모와 예측(2024-2029년)
• 시장 기회 : 최종사용자별

제9장 시장 세분화 : 서비스별

• 시장 부문
• 비교 : 서비스별
• 독성 검사 : 시장 규모와 예측(2024-2029년)
• 바이오 분석 및 DMPK 연구 : 시장 규모와 예측(2024-2029년)
• 화합물 관리 : 시장 규모와 예측(2024-2029년)
• 기타 : 시장 규모와 예측(2024-2029년)
• 시장 기회 : 서비스별

제10장 고객 상황

• 고객 상황 개요

제11장 지역별 상황

• 지역별 세분화
• 비교 : 지역별
• 북미 : 시장 규모와 예측(2024-2029년)
• 유럽 : 시장 규모와 예측(2024-2029년)
• 아시아 : 시장 규모와 예측(2024-2029년)
• 기타 : 시장 규모와 예측(2024-2029년)
• 미국 : 시장 규모와 예측(2024-2029년)
• 독일 : 시장 규모와 예측(2024-2029년)
• 영국 : 시장 규모와 예측(2024-2029년)
• 캐나다 : 시장 규모와 예측(2024-2029년)
• 중국 : 시장 규모와 예측(2024-2029년)
• 인도 : 시장 규모와 예측(2024-2029년)
• 프랑스 : 시장 규모와 예측(2024-2029년)
• 일본 : 시장 규모와 예측(2024-2029년)
• 멕시코 : 시장 규모와 예측(2024-2029년)
• 이탈리아 : 시장 규모와 예측(2024-2029년)
• 지역 상황에 의한 시장 기회

제12장 성장 촉진요인, 과제, 기회, 성장 억제요인

• 시장 성장 촉진요인
• 시장이 해결해야 할 과제
• 성장 촉진요인과 과제의 영향
• 시장 기회와 성장 억제요인

제13장 경쟁 구도

• 개요
• 경쟁 구도
• 혼란 상황
• 산업 리스크

제14장 경쟁 분석

• 기업 개요
• 기업 순위 지수
• 기업의 시장 포지셔닝
• Altasciences
• AmplifyBio
• Charles River Laboratories International Inc.
• Crown Bioscience
• Eurofins Scientific SE
• ICON plc
• Imavita S.A.S.
• IQVIA Holdings Inc.
• Kunming Biomed International Ltd.
• Laboratory Corp. of America Holdings
• Medpace Holdings Inc.
• PPD
• Veeda Clinical Research Ltd.
• Vivotecnia
• WuXi AppTec Co. Ltd.

제15장 부록

영문목차

The preclinical CRO market is forecasted to grow by USD 2734.8 million during 2024-2029, accelerating at a CAGR of 8.1% during the forecast period. The report on the preclinical CRO market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of chronic diseases, increase in technology and advancements in healthcare infrastructure, and growth in outsourcing of non-core functions related to preclinical CRO.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's preclinical CRO market is segmented as below:

By End-user

• P and B companies
• Medical device companies
• Academic institutes

By Service

• Toxicology testing
• Bioanalysis and DMPK studies
• Compound management
• Others

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the increasing number of clinical trials as one of the prime reasons driving the preclinical CRO market growth during the next few years. Also, rise in research and development budget for drug development and increasing demand for new drugs and medical treatments will lead to sizable demand in the market.

The report on the preclinical CRO market covers the following areas:

• Preclinical CRO Market sizing
• Preclinical CRO Market forecast
• Preclinical CRO Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading preclinical CRO market vendors that include Altasciences, AmplifyBio, BioEmission Technology Solutions, Charles River Laboratories International Inc., Crown Bioscience, CYNBIOSE, Eurofins Scientific SE, Gempharmatech Co. Ltd., Global Center for Medical Innovation, ICON PLC, Imavita S.A.S., IQVIA Holdings Inc., Kunming Biomed International Ltd., Laboratory Corp. of America Holdings, Medpace Holdings Inc., Parexel International Corp., PPD, Veeda Clinical Research Ltd., Vivotecnia, and WuXi AppTec Co. Ltd.. Also, the preclinical CRO market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market By Geographical Landscape
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Market Segmentation by Service
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
  • Overview on criticality of inputs and factors of differentiation
• 2.3 Factors of disruption
  • Overview on factors of disruption
• 2.4 Impact of drivers and challenges
  • Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

• 3.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market
• 3.2 Market characteristics
  • Market characteristics analysis
• 3.3 Value chain analysis
  • Value chain analysis

4 Market Sizing

• 4.1 Market definition
  • Offerings of companies included in the market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2024
• 4.4 Market outlook: Forecast for 2024-2029
  • Chart on Global - Market size and forecast 2024-2029 ($ million)
  • Data Table on Global - Market size and forecast 2024-2029 ($ million)
  • Chart on Global Market: Year-over-year growth 2024-2029 (%)
  • Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

• 5.1 Global Preclinical CRO Market 2019 - 2023
  • Historic Market Size - Data Table on Global Preclinical CRO Market 2019 - 2023 ($ million)
• 5.2 End-user segment analysis 2019 - 2023
  • Historic Market Size - End-user Segment 2019 - 2023 ($ million)
• 5.3 Service segment analysis 2019 - 2023
  • Historic Market Size - Service Segment 2019 - 2023 ($ million)
• 5.4 Geography segment analysis 2019 - 2023
  • Historic Market Size - Geography Segment 2019 - 2023 ($ million)
• 5.5 Country segment analysis 2019 - 2023
  • Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

• 6.1 The AI impact on Global Preclinical CRO Market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2024 and 2029
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2024 and 2029
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2024 and 2029
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2024 and 2029
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2024 and 2029
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2024 and 2029
• 7.7 Market condition
  • Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by End-user

• 8.1 Market segments
  • Chart on End-user - Market share 2024-2029 (%)
  • Data Table on End-user - Market share 2024-2029 (%)
• 8.2 Comparison by End-user
  • Chart on Comparison by End-user
  • Data Table on Comparison by End-user
• 8.3 P and B companies - Market size and forecast 2024-2029
  • Chart on P and B companies - Market size and forecast 2024-2029 ($ million)
  • Data Table on P and B companies - Market size and forecast 2024-2029 ($ million)
  • Chart on P and B companies - Year-over-year growth 2024-2029 (%)
  • Data Table on P and B companies - Year-over-year growth 2024-2029 (%)
• 8.4 Medical device companies - Market size and forecast 2024-2029
  • Chart on Medical device companies - Market size and forecast 2024-2029 ($ million)
  • Data Table on Medical device companies - Market size and forecast 2024-2029 ($ million)
  • Chart on Medical device companies - Year-over-year growth 2024-2029 (%)
  • Data Table on Medical device companies - Year-over-year growth 2024-2029 (%)
• 8.5 Academic institutes - Market size and forecast 2024-2029
  • Chart on Academic institutes - Market size and forecast 2024-2029 ($ million)
  • Data Table on Academic institutes - Market size and forecast 2024-2029 ($ million)
  • Chart on Academic institutes - Year-over-year growth 2024-2029 (%)
  • Data Table on Academic institutes - Year-over-year growth 2024-2029 (%)
• 8.6 Market opportunity by End-user
  • Market opportunity by End-user ($ million)
  • Data Table on Market opportunity by End-user ($ million)

9 Market Segmentation by Service

• 9.1 Market segments
  • Chart on Service - Market share 2024-2029 (%)
  • Data Table on Service - Market share 2024-2029 (%)
• 9.2 Comparison by Service
  • Chart on Comparison by Service
  • Data Table on Comparison by Service
• 9.3 Toxicology testing - Market size and forecast 2024-2029
  • Chart on Toxicology testing - Market size and forecast 2024-2029 ($ million)
  • Data Table on Toxicology testing - Market size and forecast 2024-2029 ($ million)
  • Chart on Toxicology testing - Year-over-year growth 2024-2029 (%)
  • Data Table on Toxicology testing - Year-over-year growth 2024-2029 (%)
• 9.4 Bioanalysis and DMPK studies - Market size and forecast 2024-2029
  • Chart on Bioanalysis and DMPK studies - Market size and forecast 2024-2029 ($ million)
  • Data Table on Bioanalysis and DMPK studies - Market size and forecast 2024-2029 ($ million)
  • Chart on Bioanalysis and DMPK studies - Year-over-year growth 2024-2029 (%)
  • Data Table on Bioanalysis and DMPK studies - Year-over-year growth 2024-2029 (%)
• 9.5 Compound management - Market size and forecast 2024-2029
  • Chart on Compound management - Market size and forecast 2024-2029 ($ million)
  • Data Table on Compound management - Market size and forecast 2024-2029 ($ million)
  • Chart on Compound management - Year-over-year growth 2024-2029 (%)
  • Data Table on Compound management - Year-over-year growth 2024-2029 (%)
• 9.6 Others - Market size and forecast 2024-2029
  • Chart on Others - Market size and forecast 2024-2029 ($ million)
  • Data Table on Others - Market size and forecast 2024-2029 ($ million)
  • Chart on Others - Year-over-year growth 2024-2029 (%)
  • Data Table on Others - Year-over-year growth 2024-2029 (%)
• 9.7 Market opportunity by Service
  • Market opportunity by Service ($ million)
  • Data Table on Market opportunity by Service ($ million)

10 Customer Landscape

• 10.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

11 Geographic Landscape

• 11.1 Geographic segmentation
  • Chart on Market share By Geographical Landscape 2024-2029 (%)
  • Data Table on Market share By Geographical Landscape 2024-2029 (%)
• 11.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison
• 11.3 North America - Market size and forecast 2024-2029
  • Chart on North America - Market size and forecast 2024-2029 ($ million)
  • Data Table on North America - Market size and forecast 2024-2029 ($ million)
  • Chart on North America - Year-over-year growth 2024-2029 (%)
  • Data Table on North America - Year-over-year growth 2024-2029 (%)
• 11.4 Europe - Market size and forecast 2024-2029
  • Chart on Europe - Market size and forecast 2024-2029 ($ million)
  • Data Table on Europe - Market size and forecast 2024-2029 ($ million)
  • Chart on Europe - Year-over-year growth 2024-2029 (%)
  • Data Table on Europe - Year-over-year growth 2024-2029 (%)
• 11.5 Asia - Market size and forecast 2024-2029
  • Chart on Asia - Market size and forecast 2024-2029 ($ million)
  • Data Table on Asia - Market size and forecast 2024-2029 ($ million)
  • Chart on Asia - Year-over-year growth 2024-2029 (%)
  • Data Table on Asia - Year-over-year growth 2024-2029 (%)
• 11.6 Rest of World (ROW) - Market size and forecast 2024-2029
  • Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
  • Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
  • Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
• 11.7 US - Market size and forecast 2024-2029
  • Chart on US - Market size and forecast 2024-2029 ($ million)
  • Data Table on US - Market size and forecast 2024-2029 ($ million)
  • Chart on US - Year-over-year growth 2024-2029 (%)
  • Data Table on US - Year-over-year growth 2024-2029 (%)
• 11.8 Germany - Market size and forecast 2024-2029
  • Chart on Germany - Market size and forecast 2024-2029 ($ million)
  • Data Table on Germany - Market size and forecast 2024-2029 ($ million)
  • Chart on Germany - Year-over-year growth 2024-2029 (%)
  • Data Table on Germany - Year-over-year growth 2024-2029 (%)
• 11.9 UK - Market size and forecast 2024-2029
  • Chart on UK - Market size and forecast 2024-2029 ($ million)
  • Data Table on UK - Market size and forecast 2024-2029 ($ million)
  • Chart on UK - Year-over-year growth 2024-2029 (%)
  • Data Table on UK - Year-over-year growth 2024-2029 (%)
• 11.10 Canada - Market size and forecast 2024-2029
  • Chart on Canada - Market size and forecast 2024-2029 ($ million)
  • Data Table on Canada - Market size and forecast 2024-2029 ($ million)
  • Chart on Canada - Year-over-year growth 2024-2029 (%)
  • Data Table on Canada - Year-over-year growth 2024-2029 (%)
• 11.11 China - Market size and forecast 2024-2029
  • Chart on China - Market size and forecast 2024-2029 ($ million)
  • Data Table on China - Market size and forecast 2024-2029 ($ million)
  • Chart on China - Year-over-year growth 2024-2029 (%)
  • Data Table on China - Year-over-year growth 2024-2029 (%)
• 11.12 India - Market size and forecast 2024-2029
  • Chart on India - Market size and forecast 2024-2029 ($ million)
  • Data Table on India - Market size and forecast 2024-2029 ($ million)
  • Chart on India - Year-over-year growth 2024-2029 (%)
  • Data Table on India - Year-over-year growth 2024-2029 (%)
• 11.13 France - Market size and forecast 2024-2029
  • Chart on France - Market size and forecast 2024-2029 ($ million)
  • Data Table on France - Market size and forecast 2024-2029 ($ million)
  • Chart on France - Year-over-year growth 2024-2029 (%)
  • Data Table on France - Year-over-year growth 2024-2029 (%)
• 11.14 Japan - Market size and forecast 2024-2029
  • Chart on Japan - Market size and forecast 2024-2029 ($ million)
  • Data Table on Japan - Market size and forecast 2024-2029 ($ million)
  • Chart on Japan - Year-over-year growth 2024-2029 (%)
  • Data Table on Japan - Year-over-year growth 2024-2029 (%)
• 11.15 Mexico - Market size and forecast 2024-2029
  • Chart on Mexico - Market size and forecast 2024-2029 ($ million)
  • Data Table on Mexico - Market size and forecast 2024-2029 ($ million)
  • Chart on Mexico - Year-over-year growth 2024-2029 (%)
  • Data Table on Mexico - Year-over-year growth 2024-2029 (%)
• 11.16 Italy - Market size and forecast 2024-2029
  • Chart on Italy - Market size and forecast 2024-2029 ($ million)
  • Data Table on Italy - Market size and forecast 2024-2029 ($ million)
  • Chart on Italy - Year-over-year growth 2024-2029 (%)
  • Data Table on Italy - Year-over-year growth 2024-2029 (%)
• 11.17 Market opportunity By Geographical Landscape
  • Market opportunity By Geographical Landscape ($ million)
  • Data Tables on Market opportunity By Geographical Landscape ($ million)

12 Drivers, Challenges, and Opportunity/Restraints

• 12.1 Market drivers
• 12.2 Market challenges
• 12.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2024 and 2029
• 12.4 Market opportunities/restraints

13 Competitive Landscape

• 13.1 Overview
• 13.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 13.3 Landscape disruption
  • Overview on factors of disruption
• 13.4 Industry risks
  • Impact of key risks on business

14 Competitive Analysis

• 14.1 Companies profiled
  • Companies covered
• 14.2 Company ranking index
  • Company ranking index
• 14.3 Market positioning of companies
  • Matrix on companies position and classification
• 14.4 Altasciences
  • Altasciences - Overview
  • Altasciences - Product / Service
  • Altasciences - Key offerings
  • SWOT
• 14.5 AmplifyBio
  • AmplifyBio - Overview
  • AmplifyBio - Product / Service
  • AmplifyBio - Key offerings
  • SWOT
• 14.6 Charles River Laboratories International Inc.
  • Charles River Laboratories International Inc. - Overview
  • Charles River Laboratories International Inc. - Business segments
  • Charles River Laboratories International Inc. - Key offerings
  • Charles River Laboratories International Inc. - Segment focus
  • SWOT
• 14.7 Crown Bioscience
  • Crown Bioscience - Overview
  • Crown Bioscience - Product / Service
  • Crown Bioscience - Key offerings
  • SWOT
• 14.8 Eurofins Scientific SE
  • Eurofins Scientific SE - Overview
  • Eurofins Scientific SE - Business segments
  • Eurofins Scientific SE - Key news
  • Eurofins Scientific SE - Key offerings
  • Eurofins Scientific SE - Segment focus
  • SWOT
• 14.9 ICON plc
  • ICON plc - Overview
  • ICON plc - Product / Service
  • ICON plc - Key offerings
  • SWOT
• 14.10 Imavita S.A.S.
  • Imavita S.A.S. - Overview
  • Imavita S.A.S. - Product / Service
  • Imavita S.A.S. - Key offerings
  • SWOT
• 14.11 IQVIA Holdings Inc.
  • IQVIA Holdings Inc. - Overview
  • IQVIA Holdings Inc. - Business segments
  • IQVIA Holdings Inc. - Key news
  • IQVIA Holdings Inc. - Key offerings
  • IQVIA Holdings Inc. - Segment focus
  • SWOT
• 14.12 Kunming Biomed International Ltd.
  • Kunming Biomed International Ltd. - Overview
  • Kunming Biomed International Ltd. - Product / Service
  • Kunming Biomed International Ltd. - Key offerings
  • SWOT
• 14.13 Laboratory Corp. of America Holdings
  • Laboratory Corp. of America Holdings - Overview
  • Laboratory Corp. of America Holdings - Business segments
  • Laboratory Corp. of America Holdings - Key news
  • Laboratory Corp. of America Holdings - Key offerings
  • Laboratory Corp. of America Holdings - Segment focus
  • SWOT
• 14.14 Medpace Holdings Inc.
  • Medpace Holdings Inc. - Overview
  • Medpace Holdings Inc. - Product / Service
  • Medpace Holdings Inc. - Key offerings
  • SWOT
• 14.15 PPD
  • PPD - Overview
  • PPD - Product / Service
  • PPD - Key offerings
  • SWOT
• 14.16 Veeda Clinical Research Ltd.
  • Veeda Clinical Research Ltd. - Overview
  • Veeda Clinical Research Ltd. - Product / Service
  • Veeda Clinical Research Ltd. - Key offerings
  • SWOT
• 14.17 Vivotecnia
  • Vivotecnia - Overview
  • Vivotecnia - Product / Service
  • Vivotecnia - Key offerings
  • SWOT
• 14.18 WuXi AppTec Co. Ltd.
  • WuXi AppTec Co. Ltd. - Overview
  • WuXi AppTec Co. Ltd. - Business segments
  • WuXi AppTec Co. Ltd. - Key offerings
  • WuXi AppTec Co. Ltd. - Segment focus
  • SWOT

15 Appendix

• 15.1 Scope of the report
• 15.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 15.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 15.4 Research methodology
  • Research methodology
• 15.5 Data procurement
  • Information sources
• 15.6 Data validation
  • Data validation
• 15.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 15.8 Data synthesis
  • Data synthesis
• 15.9 360 degree market analysis
  • 360 degree market analysis
• 15.10 List of abbreviations
  • List of abbreviations